Tenax Therapeutics, Inc (TENX)

CIK 34956 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Tenax Therapeutics, Inc.

Recent SEC filings

FiledFormAccession number
Nov 5, 202610-Q0001193125-26-449796
Nov 5, 20268-K0001193125-26-448517
Oct 27, 2026SCHEDULE 13G/A0002012383-26-003851
Oct 21, 202640001940272-26-000027
Oct 15, 2026SCHEDULE 13G/A0001104659-26-116300
Oct 13, 2026SCHEDULE 13G/A0001178913-26-004757
Oct 9, 2026SCHEDULE 13G/A0001943462-26-000008
Oct 8, 20268-K0001193125-26-417939
Sep 17, 202640001193125-26-394831
Sep 15, 202640001193125-26-392319
Sep 15, 202640001871714-26-000002
Sep 11, 2026SCHEDULE 13G/A0001140361-26-036327
Sep 9, 20268-K0001193125-26-385910
Sep 8, 202640001940272-26-000020
Sep 8, 2026SCHEDULE 13G/A0000315066-26-002289
Sep 8, 2026SCHEDULE 13G0001104659-26-105941
Sep 2, 202640001940272-26-000019
Aug 27, 2026SCHEDULE 13G0001178913-26-004262
Aug 27, 2026SCHEDULE 13G0001140361-26-034749
Aug 24, 202630001940272-26-000016
Aug 24, 202640001940272-26-000017
Aug 18, 2026SCHEDULE 13G0001104659-26-098450
Aug 14, 2026SCHEDULE 13G/A0001493215-26-000159
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352960
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000935